January 14 - 16, 2013    Washington DC , Estados Unidos
This global three-day program will provide new insights into the current issues and associated challenges impacting drug safety, focusing primarily on drug products and biologics, throughout all phases of development and marketed use. Top pharmaceutical, biotech and regulatory representatives who are experts in their field will discuss new and updated legislation in various ICH regions, current regulatory framework for pharmacovigilance in global regions, operational challenges of implementing global benefit-risk analyses and risk management plans, the impact of social media, and the role of epidemiology in safety analysis.


Featured Topics

Global regulatory updates
New EU regulations
Periodic benefit-risk evaluation reports
Benefit-risk analysis
Use of existing automated databases
Epidemiology
Social media

Lugar

Location: Renaissance Washington D C Hotel Downtown
Contact 999 Ninth St NW. Washington , USA

Eventos relacionados

Pharmacovigilence and Risk Management Strategies Meeting January 22 - 24, 2018
Pharmacovigilence and Risk Management Strategies January 23 - 25, 2017
Pharmacovigilence and Risk Management Strategies Meeting January 26 - 28, 2015
Pharmacovigilence and Risk Management Strategies January 13 - 15, 2014
Pharmacovigilence and Risk Management Strategies USA January 14 - 16, 2013
Pharmacovigilence & Risk Management Strategies - USA January 23 - 25, 2012